Panacea Global, Inc.
| OTC Markets: PANG
Panacea Global, Inc. is a biotechnology company focused on the discovery, development and commercialization of diagnostic products for the management of cancer. The company provides blood, serum and tissue tests to diagnose and monitor cancer through a licensing agreement with Panacea Pharmaceuticals. Its current product line allows for accurate detection of the most common forms of cancer, which includes diagnostic tests for lung, breast, prostate and colon cancers. The company was founded on February 5, 2010 and is headquartered in Richmond Hill, Canada.